Literature DB >> 9361286

Proteoglycans provide neurite guidance at an astrocyte boundary.

E M Powell1, J W Fawcett, H M Geller.   

Abstract

Astrocytes in the developing brain direct neurites through their synthesis of cell surface and extracellular matrix molecules. We introduce a novel culture system to identify and examine the guidance properties of astrocyte-derived molecules. The permissive A7 and nonpermissive Neu7 cell lines were co-cultured to form an A7/Neu7 monolayer. Neurites extended on A7 cells but avoided Neu7 cells and instead stopped or turned at the A7/Neu7 Interface. Enzymatic treatment with trypsin and hyaluronic acid increased neurite extension, but neither altered the boundary. Only, removal of keratan and chondroitin sulfate residues reduced the guidance capacity of the A7/Neu7 boundary. Since no treatment individually abolished the boundary, neurite guidance appears to be due to a combination of factors. The A7/Neu7 astrocyte substrate demonstrates the functional role for KSPGs and CSPGs, but more interestingly, suggests that simply increasing the capacity of a substrate to permit neurite outgrowth does not necessarily eliminate or even reduce its guidance properties.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9361286     DOI: 10.1006/mcne.1997.0629

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  10 in total

1.  Gene delivery to overcome astrocyte inhibition of axonal growth: an in vitro model of the glial scar.

Authors:  Hannah M Tuinstra; Melissa M Ducommun; William E Briley; Lonnie D Shea
Journal:  Biotechnol Bioeng       Date:  2012-11-01       Impact factor: 4.530

2.  Tenascin-C contains domains that independently regulate neurite outgrowth and neurite guidance.

Authors:  S Meiners; M L Mercado; M S Nur-e-Kamal; H M Geller
Journal:  J Neurosci       Date:  1999-10-01       Impact factor: 6.167

3.  Neonatal vaccination with bacille Calmette-Guérin promotes the dendritic development of hippocampal neurons.

Authors:  Qingqing Li; Yuwei Zhang; Juntao Zou; Fangfang Qi; Junhua Yang; Qunfang Yuan; Zhibin Yao
Journal:  Hum Vaccin Immunother       Date:  2015-09-16       Impact factor: 3.452

4.  Myosin II activity regulates neurite outgrowth and guidance in response to chondroitin sulfate proteoglycans.

Authors:  Panpan Yu; Lizzie Y Santiago; Yasuhiro Katagiri; Herbert M Geller
Journal:  J Neurochem       Date:  2012-02-06       Impact factor: 5.372

5.  Spinal cord injury elicits expression of keratan sulfate proteoglycans by macrophages, reactive microglia, and oligodendrocyte progenitors.

Authors:  Leonard L Jones; Mark H Tuszynski
Journal:  J Neurosci       Date:  2002-06-01       Impact factor: 6.167

6.  Smad proteins differentially regulate transforming growth factor-β-mediated induction of chondroitin sulfate proteoglycans.

Authors:  Bala T S Susarla; Eric D Laing; Panpan Yu; Yasuhiro Katagiri; Herbert M Geller; Aviva J Symes
Journal:  J Neurochem       Date:  2011-10-03       Impact factor: 5.372

7.  Comparing astrocytic cell lines that are inhibitory or permissive for axon growth: the major axon-inhibitory proteoglycan is NG2.

Authors:  P S Fidler; K Schuette; R A Asher; A Dobbertin; S R Thornton; Y Calle-Patino; E Muir; J M Levine; H M Geller; J H Rogers; A Faissner; J W Fawcett
Journal:  J Neurosci       Date:  1999-10-15       Impact factor: 6.167

Review 8.  "Targeting astrocytes in CNS injury and disease: A translational research approach".

Authors:  Angela R Filous; Jerry Silver
Journal:  Prog Neurobiol       Date:  2016-03-26       Impact factor: 11.685

Review 9.  The role of astrocytes in mediating exogenous cell-based restorative therapy for stroke.

Authors:  Yi Li; Zhongwu Liu; Hongqi Xin; Michael Chopp
Journal:  Glia       Date:  2013-11-04       Impact factor: 7.452

10.  Structural synaptic elements are differentially regulated in superior temporal cortex of schizophrenia patients.

Authors:  Andrea Schmitt; Fernando Leonardi-Essmann; Pascal F Durrenberger; Sven P Wichert; Rainer Spanagel; Thomas Arzberger; Hans Kretzschmar; Mathias Zink; Mario Herrera-Marschitz; Richard Reynolds; Moritz J Rossner; Peter Falkai; Peter J Gebicke-Haerter
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-03-23       Impact factor: 5.270

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.